Abbott Laboratories Stock Ownership

Insider buying vs selling

Have Abbott Laboratories insiders been buying or selling?
William A. OsbornDirector2020-11-2521,448$43.64
Robert E. FunckExecutive Vice President & CFO2020-10-2883,333$108.83
Robert E. FunckExecutive Vice President & CFO2020-10-2883,333$38.40
Andrea F. WainerExecutive Vice President2020-10-0130,000$38.40
Andrea F. WainerExecutive Vice President2020-10-0130,000$107.01
Andrea F. WainerExecutive Vice President2020-09-253,650$102.47
Randel William WoodgriftSenior Vice President2020-09-152,500$105.28
Roger BirdSenior Vice President2020-09-036,290$108.73
John F. GinascolExecutive Vice President2020-09-0347,772$109.47
John F. GinascolExecutive Vice President2020-09-0339,953$44.40

1 of 11

ABT insiders have sold more ABT shares than they have bought in the last year

ABT Shareholders

What type of owners hold Abbott Laboratories stock?
We're currently working to improve the accuracy of the Shareholders dataset. If you spot any inaccuracies, let us know at contact (at) wallstreetzen.com
Vanguard Group Inc8.37%148,155,501$15.94BInstitution
Blackrock Inc7.63%135,019,032$14.53BInstitution
Capital Research Global Investors4.94%87,413,660$9.41BInstitution
State Street Corp4.16%73,674,771$7.93BInstitution
Capital International Investors3.16%55,977,647$6.02BInstitution
Wellington Management Group Llp1.98%35,005,383$3.77BInstitution
Northern Trust Corp1.53%27,028,098$2.91BInstitution
Bank Of America Corp1.49%26,317,545$2.83BInstitution
Massachusetts Financial Services Co1.45%25,721,656$2.77BInstitution
Morgan Stanley1.43%25,371,069$2.73BInstitution

1 of 3

Abbott Laboratories Stock Ownership FAQ

Abbott Laboratories (NYSE: ABT) is owned by 72.64% institutional shareholders, 1.08% Abbott Laboratories insiders, and 26.28% retail investors. Vanguard Group Inc is the largest individual Abbott Laboratories shareholder, owning 148.16M shares representing 8.37% of the company. Vanguard Group Inc's Abbott Laboratories shares are currently valued at $15.94B.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics